RAUORA phase III trial of cytisinicline shows non-inferiority to Chantix in smoking cessation.- Achieve Life Sciences
Achieve Life Sciences announced the successful topline results from the New Zealand RAUORA Phase III non-inferiority clinical trial comparing cytisinicline to Chantix (varenicline) in Maori (indigenous New Zealanders)… read more.